Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
Marijuana Industry
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis
InMed Pharmaceuticals, Inc. has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids.
Biotechs Develop Proprietary Systems to Drive CBD Research and Development
With a market that’s expected to grow from $2 billion in 2020 to $50 billion in only nine years, according to Statista, biotechnology companies are increasingly focused on the development of proprietary systems and procedures to drive research and production of cannabinoid pharmaceuticals.
Marijuana Company of America, Inc. (MCOA) Building Momentum as Legalization Push Gains Steam
Marijuana Company of America, Inc. (OTC: MCOA) is building upon its vertically integrated business strategy by taking a unique approach to how companies within the industry position themselves in the marketplace.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC.
Marijuana Company of America, Inc. (MCOA) Offers Portfolio of Promise in Cannabis and Hemp
With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 42% Month-Over-Month Revenue Growth in October
PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million.
Rising Demand for Cannabis Oils Pushes Canada’s Producers into Overdrive
As one of Canada’s first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities.
Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Coming Cannabis Recreational Demand in Canada Triggers Massive Investment
The Canadian government’s commitment to legalize recreational cannabis in July 2018 is touted as an opportunity for investors to profit from the ongoing green blitz.